In a filing, Atara Biotherapeutics Inc revealed its President and CEO Touchon Pascal unloaded Company’s shares for reported $17888.0 on Mar 04 ’24. In the deal valued at $0.72 per share,24,844 shares were sold. As a result of this transaction, Touchon Pascal now holds 1,910,652 shares worth roughly $1.47 million.
Then, Nguyen AnhCo sold 10,746 shares, generating $7,737 in total proceeds. Upon selling the shares at $0.72, the EVP, Chief Sci. & Tech Officer now owns 941,397 shares.
Before that, Murugan Amar sold 10,044 shares. Atara Biotherapeutics Inc shares valued at $7,232 were divested by the EVP, Chief Legal Officer at a price of $0.72 per share. As a result of the transaction, Murugan Amar now holds 727,521 shares, worth roughly $0.56 million.
Mizuho downgraded its Atara Biotherapeutics Inc [ATRA] rating to a Neutral from a a Buy in a research note published on November 09, 2023; the price target was decreased to $1 from $31. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who decreased its forecast for the stock in early November from “a Buy” to “a Neutral”. Evercore ISI also remained covering ATRA and has decreased its forecast on November 09, 2023 with a “an In-line” recommendation from previously “an Outperform” rating. Citigroup revised its rating on July 20, 2022. It rated ATRA as “a Sell” which previously was an “a Neutral”.
Price Performance Review of ATRA
On Friday, Atara Biotherapeutics Inc [NASDAQ:ATRA] saw its stock fall -0.62% to $0.77. Over the last five days, the stock has gained 11.54%. Atara Biotherapeutics Inc shares have risen nearly 50.96% since the year began. Nevertheless, the stocks have fallen -72.84% over the past one year. While a 52-week high of $3.08 was reached on 02/02/24, a 52-week low of $0.20 was recorded on 01/03/24. SMA at 50 days reached $0.7526, while 200 days put it at $1.1586. A total of 1.2 million shares were traded, compared to the trading of 0.8 million shares in the previous session.
Levels Of Support And Resistance For ATRA Stock
The 24-hour chart illustrates a support level at 0.7287, which if violated will result in even more drops to 0.6834. On the upside, there is a resistance level at 0.8257. A further resistance level may holdings at 0.8774. The Relative Strength Index (RSI) on the 14-day chart is 57.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0566, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 24.14%. Stochastics %K at 77.97% indicates the stock is a holding.
How much short interest is there in Atara Biotherapeutics Inc?
A steep rise in short interest was recorded in Atara Biotherapeutics Inc stocks on Mar 15, 2024, growing by 0.16 million shares to a total of 11.03 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 10.87 million shares. There was a rise of 1.45%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 11.09% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.32.
